and Oxford, are undertaking careful studies, as much more information is needed about the mode of action of cestrogens and their long-term effects. Yours sincerely
From Professor P J Huntingford Department of Obstetrics & Gynacology, The London Hosptial (Mile End), London El 4DG Sir, Your report (June Proceedings, p 423) 'Hormone Replacement Therapy and the General Practitioner' raises some interesting issues. I agree completely with Mrs Jean Robinson that there is a need for doctors to listen and to take much more notice of menopausal symptoms, but we should be careful to avoid assuming that all emotional and psychological disturbances at the time of the menopause can be relieved by an attractive packet of pills. Our society is only too ready to take the short cut. It is easier to write a prescription than to listen to problems, which are the product of our social organization and, in particular, of the role that middle-aged women are forced to play. I am glad that 'liberated women' are not likely to accept decades of steroid therapy as your report suggests they may. Such women are much more likely to reject glib medical reassurance that a pill a day will resolve all their problems. Neither are they likely to accept without question the motives of the pharmaceutical industry supporting menopausal clinics.
I welcome technological advance to make people less and not more dependent on doctors, and to enable us to spend more time listening to each other. Yours for risk factors known at present do not fully account for its occurrence. One suggestion has been that coronary disease is frequently the consequence of 'premyxcedema'. This was defined by Dr Fowler et al. (1970, Lancet ii, 488) as a state of early thyroid failure in which normal plasma thyroid hormone levels are maintained by an increased secretion of TSH and in which hypercholesterolhmia is a characteristic feature. Circulating thyroid antibodies were said to be a common finding. Thus hypercholesterolhmia was due to thyroid disease, but occurred in the absence of clinical evidence of hypothyroidism and in the presence of normal plasma levels of thyroid hormone. This entity has been held by Dr Fowler to be a common cause of ischemic heart disease in the community, presumably mediated by hypercholesterolmmia (May Proceedings, p 297).
In several years of running a lipid clinic I have seen some 1500 hyperlipidaemic patients, many of them with ischemic heart disease. Underlying causes were often present, amongst which overt hypothyroidism was prominent. For five years, our routine investigations for secondary hyperlipidewmia included TSH assay. On no occasion did this lead to a clinically-unsuspected diagnosis of hypothyroidism. This experience is quite at variance with that of Baschieri et al., quoted in Dr Fowler's editorial.
Is the triad of ischemic heart disease, hyperlipidcmia and the presence of thyroid antibodies a recognizable entity? Heinonen et al. (1972, Lancet i, 785) have failed to confirm an association between ischtmic heart disease and thyroid antibodies. Tunbridge (1976, MD Thesis, University of Cambridge) observed no significant association in a community study, between thyroid antibodies or high TSH levels and serum lipid concentration or lipoprotein patterns. However, a high TSH was associated in women, but not in men, with minor ECG abnormalities and with symptoms suggestive of cardiac ischemia.
A further reason for questioning the importance of the concept of premyxcedema, is the absence of any plausible mechanism by which early thyroid disease could result in hypercholesterolemia.
Plasma levels of thyroid hormone are by definition normal; I do not see how the hepatic mechanisms for excretion and degradation of cholesterol could anticipate future thyroid insufficiency. This leaves the possibility that high TSH levels might lead to chronic hypercholesterolemia in man. While TSH might increase free fatty acid mobilization, this would be expected to result, if anything, in a hyperlipidwemia in which increased triglyceride levels would be most prominent, rather than in hypercholesterolhmia.
Underlying causes should always be sought in patients with substantial hypercholesterolkmia, and a treatable cause such as hypothyroidism should not be missed. But the status of premyxcedema as a common entity is highly questionable on the basis of existing cross-sectional data (Durack D T & Beeson P B, 1972, British Journal ofExperimental Pathology 53, 44 49) . The experiments were part of a study (supported by a British Heart Foundation grant) using a variety of oral isolates, and the initiation of infection with Lactobacillus casei occurred as readily as with streptococcal species. Chains of lactobacilli were seen arising from the surface in a scanning electron microscope preparation of a vegetation from one infected animal (Fig 1) .
A possible oral source of infection is mentioned in 9 of the 14 published cases of lactobacillus endocarditis (adding the cases of Berger et al. Dr Isenberg's list of cases). A definite preceding incident of dental treatment is mentioned in only 5 cases and care must be taken to avoid the assumption that the mere presence of dental caries can lead to bacteremia. Nevertheless, this is a remarkably high proportion. It is surprising that these relatively common oral micro-organisms have seldom been identified as constituents of postextraction bacterxmia. The explanation may well lie in the fastidious culture requirements which, as Isenberg and others have suggested, help to make the isolation of lactobacilli in , has surveyed the subject in great detail, but I am sure he would agree that the most important section is the one on management. The idea that the progress of medicine has been emulated in the treatment of the disease could be extended, for the management (or mismanagement) of the condition is a minature of the way in which bacterial infections of the nervous system are treated. As Professor Yarington says, it is tragic that clinicians, faced for once with a neurological disorder that can be cured, should so often allow disasters to occur because they procrastinate or prescribe treatment which is inadequate in quality or quantity. The precepts that treatment must start at once, and that the possibility of agranulocytosis in ten years time is no threat to a man destined to die within ten days, cannot be overemphasized. Similarly, those accustomed to prescribing a few thousand units of penicillin two or three times a day may need to be reminded that 'large doses' means at least two million units intravenously every two hours. One point which Professor Yarington does not discuss is the length of time for which treatment should be given. Relapses and death due to latent abscesses have often been reported and some advocate the giving of antibiotics for as long as three months. It may be that computerized axial tomography will prove to be of value in identifying patients likely to need such prolonged treatment.
Where other drugs are concerned I share Professor Yarington's view that streptokinase and allied substances should only be used by experts, for their value does not seem to have been established and some are difficult to manage. It is harder
